Proud to present ... Impact of Particle Therapy, Vols 1 and 2
Vol 1: redjournal.org/issue/S0360-3…
Vol 2: redjournal.org/issue/S0360-3…
More than just protons, more than just retrospective reviews ... prospective data, candid opinions, science, innovations, future space
New in #RedJournal: Adaptive SBRT boost (30 Gy/5 fx) to residual primary tumor after CRT in unresectable stage III NSCLC without immunotherapy. 2-yr OS 61.5%; BED >94.77 Gy & 3-mo SUVmax ≥4.55 predict locoregional control. tinyurl.com/rjekiraz
Check out this #RedJournal article from @NRGOnc on the neurocognitive function and quality of life results from a phase II study (NRG/RTOG 0424) of temozolomide-based chemoradiotherapy regimen for high-risk low-grade gliomas. tinyurl.com/rjjswefel
🎙️ New #RedJournal Podcast:
Proton Therapy Meets Clinical Trials - 11/15/2026
Editor-in-Chief Sue Yom talks with four investigators of proton therapy clinical trials. Guests include: Dr. Xing Liao, Dr. Jean Wright, Dr. Shannon Macdonald, and Dr. Nancy Mendenhall.
Listen on YouTube: bit.ly/4Aws5Uo
Listen on Spotify: bit.ly/4AswjfB
Listen online: bit.ly/4zed7RF@IJROBP
Happy to share our new study in @IJROBP and presented today at @NeuroOnc, led by Dr. Lauren Linkowski, @MessingIan, Melanie Berger.
Glioblastoma remains a disease with few effective therapies and often recurs within a year despite multi-modality treatment.
We evaluated hypofractionated proton re-irradiation for patients with recurrent glioblastoma.
🔗 redjournal.org/article/S0360…
🫀 Can proton therapy make breast cancer radiotherapy safer for the heart?
A 2026 review in @IJROBP highlights:
🔹 Better heart & lung sparing, especially with internal mammary node irradiation
🔹 Modern IMPT allows tailored skin-dose optimization
🔹 RADCOMP (n=1,239): Similar early quality-of-life outcomes with protons vs photons
⚠️ The big question remains unanswered: Does lower cardiac radiation translate into fewer cardiac events?
The randomized long-term cardiac and cancer-control outcomes are still awaited.
💡 Verdict: Dosimetric superiority is established. Clinical superiority remains to be proven.
@oncoalert#BreastCancer#RadiationOncology
Full paper link in comment below ⬇️.
1/ Radiation therapy has long been planned as if the same dose has the same effect in every tissue and every patient.
In our new @IJROBP editorial with Harald Paganetti, we propose a way to change that. 🧵
🎥 New #RedJournal Outtake:
Dr. Sheila H. Ridner on Long-Term Outcomes of Advanced Pneumatic Compression Device - Oct. 21, 2026
Watch on YouTube: bit.ly/4sQyw1Z
Watch online: bit.ly/4iARnKP@IJROBP
New #RedJournal Podcast: An ASTRO Special! Productivity Metrics, Inside and Outside the RVU
Sue Yom, Editor in Chief, hosts a discussion of "Measure What Matters: Rethinking Surrogate Metrics of Success in Radiation Oncology," with guests Dr. Shraddha Dalwadi and Dr. Amar Rewari.
Listen on Youtube: bit.ly/4szzEqn
Listen on Spotify: bit.ly/4iqTIXg
Listen online: bit.ly/3W2BCUl@IJROBP@sueyom@loveandmedicine@DrAmarExplains
New in the @IJROBP : breast RT + SIB in 5 fractions, with low objective late side effects at 5 years.
Congratulations to Maia Dzhugashvili this paper forms part of her PhD thesis and all coauthors!
🔗 authors.elsevier.com/sd/arti…